GL1X · GenesisL1 explorer

MolNFT v1 · #188246 · protein

Crystal structure of SARS-cov-2 3CL in complex with inhibitor NK01-48

7TIY · 3C-like proteinase NSP5: “Crystal structure of SARS-cov-2 3CL in complex with inhibitor NK01-48”. X-ray diffraction, 2 ligands (Y48, PO4), 2 pockets (best druggability 0.56). MolNFT v1 #188246 on GenesisL1: 3D structure, binding…

PDB
7TIY
Type
protein
Length
302 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase NSP5
EC
3.4.22.69
UniProt
P0DTC1
Ligands
Y48, PO4
Pockets
2 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 25% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase NSP5 (EC 3.4.22.69)protein30225% helix, 29% strandP0DTC1

Ligands and binding sites

  • Y48 · (1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-[(N-{[(2,4,5-trifluorophenyl)methoxy]carbonyl}-L-leucyl) amino]propane-1-sulfonic acid · ligand · chains A
  • PO4 · Phosphate ion · ion · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12190.560.7930Y48
2640.300.7414empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7TIY · Crystal structure of SARS-CoV-2 3CL in complex with inhibitor NK01-48 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.